SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10881249
Source:
http://linkedlifedata.com/resource/pubmed/id/10881249
Search
Subject
(
71
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0014556
,
umls-concept:C0016293
,
umls-concept:C0019564
,
umls-concept:C0030705
,
umls-concept:C0039485
,
umls-concept:C0205098
,
umls-concept:C0876934
,
umls-concept:C1167622
,
umls-concept:C1707520
pubmed:issue
12
pubmed:dateCreated
2000-7-31
pubmed:abstractText
To detect reduced [11C]flumazenil in patients with temporal lobe epilepsy (TLE) and to relate binding to histopathology.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/Flumazenil
,
http://linkedlifedata.com/resource/pubmed/chemical/GABA Modulators
,
http://linkedlifedata.com/resource/pubmed/chemical/Valproic Acid
,
http://linkedlifedata.com/resource/pubmed/chemical/Vigabatrin
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0028-3878
pubmed:author
pubmed-author:JutilaLL
,
pubmed-author:KälviäinenRR
,
pubmed-author:LamusuoSS
,
pubmed-author:LehikoinenPP
,
pubmed-author:NågrenKK
,
pubmed-author:OikonenVV
,
pubmed-author:PartanenKK
,
pubmed-author:PitkänenAA
,
pubmed-author:RinneJ OJO
,
pubmed-author:RuottinenH MHM
,
pubmed-author:VainioPP
,
pubmed-author:VapalahtiMM
,
pubmed-author:YlinenAA
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2252-60
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10881249-Adolescent
,
pubmed-meshheading:10881249-Adult
,
pubmed-meshheading:10881249-Anticonvulsants
,
pubmed-meshheading:10881249-Benzodiazepines
,
pubmed-meshheading:10881249-Epilepsy, Temporal Lobe
,
pubmed-meshheading:10881249-Female
,
pubmed-meshheading:10881249-Flumazenil
,
pubmed-meshheading:10881249-GABA Modulators
,
pubmed-meshheading:10881249-Hippocampus
,
pubmed-meshheading:10881249-Humans
,
pubmed-meshheading:10881249-Magnetic Resonance Imaging
,
pubmed-meshheading:10881249-Male
,
pubmed-meshheading:10881249-Middle Aged
,
pubmed-meshheading:10881249-Temporal Lobe
,
pubmed-meshheading:10881249-Tomography, Emission-Computed
,
pubmed-meshheading:10881249-Treatment Outcome
,
pubmed-meshheading:10881249-Valproic Acid
,
pubmed-meshheading:10881249-Vigabatrin
pubmed:year
2000
pubmed:articleTitle
[11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology.
pubmed:affiliation
Department of Neurology, University of Turku, Finland.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Controlled Clinical Trial
,
Research Support, Non-U.S. Gov't